Bulky Nonproteinogenic Amino Acids Permit the Design of Very Small and Effective Cationic Antibacterial Peptides

Citations Over TimeTop 20% of 2004 papers

Abstract

The rate of multidrug-resistant infections is rapidly rising. Cationic antibacterial peptides are active against resistant pathogens and have low propensity for resistance development, but because of their unfavorable medicinal properties, cationic antibacterial peptides have been a limited clinical success. We have found that introduction of nongenetically coded amino acids and other lipophilic modifications opens the opportunity for development of extremely short and highly active antibacterial peptides with improved medicinal properties.

Related Papers

• → DOSE-DEPENDENT EFFECTS OF ANTIBACTERIAL ACTIVITY OF SYNTHETIC PEPTIDES ISOLATED FROM GM-CSF ACTIVE CENTER(2014)
• Study on Antibacterial Peptides Application in Meat Products of Low Temperature(2006)
• A Study on Antibacterial Activity of Antibacterial Peptide From Lucilia sericata After Treatment at High Temperature(2005)
• Biological Properties and Preliminary Purification of Antibacterial Peptide from Tenebrio molitor(2009)
• Study on the Antibacterial Mechanism of a Glycine-Rich Antibacterial Peptide SK_(66) of Drosophila(2012)